Michael Sesay, MD | |
217 E 7th St, Anniston, AL 36207-5725 | |
(256) 237-1535 | |
(256) 237-5053 |
Full Name | Michael Sesay |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 24 Years |
Location | 217 E 7th St, Anniston, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073735098 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 57008429 (Ohio) | Secondary |
207Q00000X | Family Medicine | 28353 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southerncare New Beacon Of Anniston | Anniston, AL | Hospice |
Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
Diversicare Of Oxford | Oxford, AL | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Michael Sesay Md, Llc | 4183792310 | 2 |
News Archive
In this Global Network for Neglected Tropical Diseases "End the Neglect" blog post, Alanna Shaikh, an expert in health consulting and writer for U.N. Dispatch, examines the burden of neglected tropical diseases (NTDs) in the developed world, highlighting findings from an article published in PLoS in July looking at Europe's NTD burden.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.
› Verified 3 days ago
Entity Name | Anniston Gastroenterology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083764526 PECOS PAC ID: 1355378118 Enrollment ID: O20050722000687 |
News Archive
In this Global Network for Neglected Tropical Diseases "End the Neglect" blog post, Alanna Shaikh, an expert in health consulting and writer for U.N. Dispatch, examines the burden of neglected tropical diseases (NTDs) in the developed world, highlighting findings from an article published in PLoS in July looking at Europe's NTD burden.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.
› Verified 3 days ago
Entity Name | Michael Sesay Md, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750530341 PECOS PAC ID: 4183792310 Enrollment ID: O20081001000348 |
News Archive
In this Global Network for Neglected Tropical Diseases "End the Neglect" blog post, Alanna Shaikh, an expert in health consulting and writer for U.N. Dispatch, examines the burden of neglected tropical diseases (NTDs) in the developed world, highlighting findings from an article published in PLoS in July looking at Europe's NTD burden.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Sesay, MD 217 E 7th St, Anniston, AL 36207-5725 Ph: (256) 237-1535 | Michael Sesay, MD 217 E 7th St, Anniston, AL 36207-5725 Ph: (256) 237-1535 |
News Archive
In this Global Network for Neglected Tropical Diseases "End the Neglect" blog post, Alanna Shaikh, an expert in health consulting and writer for U.N. Dispatch, examines the burden of neglected tropical diseases (NTDs) in the developed world, highlighting findings from an article published in PLoS in July looking at Europe's NTD burden.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.
› Verified 3 days ago
Dr. Corey Gilliland, DO, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave Ste 200, Anniston, AL 36207 Phone: 256-235-5972 Fax: 256-231-2583 | |
Robert Lamar Cater, MD,AAFP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Greenbrier Dear Rd, Anniston, AL 36207 Phone: 256-770-4327 Fax: 256-770-4309 | |
Donald Wayne Casey, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 Quintard Ave, Suite B, Anniston, AL 36201 Phone: 256-236-9400 Fax: 256-238-1498 | |
Dr. David A Chalk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 8th St, Anniston, AL 36207 Phone: 256-237-8527 Fax: 256-237-0208 | |
Seth Garrett, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 701 Leighton Ave, Anniston, AL 36207 Phone: 256-231-1231 Fax: 256-231-1232 | |
Dr. Nadia Jonelle Mckitty, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 217 E 7th St, Anniston, AL 36207 Phone: 256-237-1535 |